Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 75 76 77 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Universität zu Lübeck. (1/12/12). "Pressemitteilung: Gründung des BioMedTec Wissenschaftscampus. Der starke Verbund für das Wissenschafts- und Wirtschaftscluster Biomedizintechnik im Norden". 2012-01-12
Novalix S.A.S.. (1/12/12). "Press Release: Novalix Enters into Multi-target Integrated Drug Discovery Collaboration with Teijin Pharma". Strasbourg. 2012-01-12
CellGenix GmbH. (1/12/12). "Press Release: CellGenix Is a Partner in InnovaLiv, a Major Multidisciplinary Regenerative Medicine Project Funded by the European Commission". 2012-01-12
Biocat. (1/12/12). "Press Release: Intelligent Pharma Opens Subsidiary in United States. This New Subsidiary, Based in Cambridge (Massachusetts), Is the Third International Office This Biotech Company Has Opened in Less than Two years". 2012-01-12
Evotec AG. (1/11/12). "Press Release: Evotec Receives 4th Milestone Payment in 2011 as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2012-01-11
Organobalance GmbH. (1/11/12). "Press Release: Organobalance Signs Licensing Agreement with Sanofi Pasteur. Modified Strain of Yeast Paves Way for New Industrial Vaccine Production Process". Berlin. 2012-01-11
Tecan Group Ltd.. (1/10/12). "Press Release: Tecan’s Infinite M1000 and a Plate of Live Fish!". Männedorf. 2012-01-10
Thermo Fisher Scientific Inc.. (1/10/12). "Press Release: Thermo Fisher Scientific Couples Chromatography and Mass Spec Systems to Develop Method for Detecting Arsenic in Apple Juice". Bremen. 2012-01-10
Ventana Medical Systems, Inc.. (1/10/12). "Press Release: Ventana to Collaborate with Pfizer and CST on Companion Diagnostic to Identify Lung Cancer Patients with ALK Gene Rearrangements. Collaboration a Significant Step in the War against Non-small Cell 2012-01-10
Genedata AG. (1/10/12). "Press Release: Genedata Screener 10 Announced at CHI High-Content Analysis Conference". San Francisco, CA. 2012-01-10
Bayer AG. (1/10/12). "Press Release: Phase III Data of Bayer’s Regorafenib in Patients with Metastatic Colorectal Cancer to Be Presented as Late Breaking Oral Presentation at 2012 ASCO-GI Congress". Berlin. 2012-01-10
GATC Biotech AG. (1/10/12). "Press Release: GATC Biotech and LifeCodexx Complete Recruitment of Blood Samples for Clinical Study of Trisomy 21 Diagnostic Test. Results of Study to Be Available in the First Quarter 2012". Constance. 2012-01-10
Qiagen GmbH. (1/10/12). "Press Release: Qiagen Receives Regulatory Approval in Japan for EGFR Companion Diagnostic to Guide Cancer Treatments". Tokyo & Hilden. 2012-01-10
Qiagen GmbH. (1/10/12). "Press Release: Qiagen Gains Rights to Genomic Biomarkers for Lung, Brain and other Cancers to Expand Its Pipeline of Companion Diagnostics". Hilden & Germantown, MD. 2012-01-10
Bayer AG. (1/9/12). "Press Release: Bayer HealthCare to Share Lab Space with Start-up Companies". San Francisco, CA. 2012-01-09
Nikem Research S.r.l.. (1/9/12). "Press Release: Nikem Research Srl and Dualsystems Biotech AG Announce a Strategic Alliance". Branzate & Schlieren. 2012-01-09
Micromet, Inc.. (1/9/12). "Press Release: Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab". Rockville, MD. 2012-01-09
Proteros Biostructures GmbH. (1/9/12). "Press Release: Janssen Pharmaceutica NV and Proteros Expand Relationship and Enter into Global Agreement". Martinsried. 2012-01-09
Qiagen GmbH. (1/9/12). "Press Release: Qiagen and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals with Latent Infection". Hilden & Berlin. 2012-01-09
Scil Technology GmbH. (1/9/12). "Press Release: Nanohale AG Acquires R&D and Service Units of Scil Technology GmbH. Transaction Creates New Nanohale Subsidiary Named Formycon GmbH". Dortmund & Martinsried. 2012-01-09
Wilex AG. (1/9/12). "Press Release: Wilex AG Resolves Rights Issue Using Authorised Capital [Ad-hoc release pursuant to § 15 Wertpapierhandelsgesetz (German Securities Trading Act)]". Munich. 2012-01-09
BioM Biotech Cluster Development GmbH. (1/9/12). "Pressemitteilung: Bayerische »Systembiologie« – BioSysNet. Start mit vier neuen Nachwuchsforschergruppen". 2012-01-09
Biocartis S.A.. (1/9/12). "Press Release: Biocartis Appoints Clark Harrison as Chief Operating Officer". Lausanne. 2012-01-09
Universität zu Lübeck. (1/6/12). "Pressemitteilung: Gründung des BioMedTec Wissenschaftscampus. Einladung zum Pressegespräch am Donnerstag, dem 12. Januar, um 14 Uhr im Hörsaalzentrum der Universität und der Fachhochschule Lübeck". 2012-01-06
Qiagen N.V.. (1/6/12). "Press Release: Qiagen Launches QIAensemble Decapper Sample Preparation Automation System". Hilden & Germantown, MD. 2012-01-06
AiCuris GmbH & Co. KG. (1/5/12). "Press Release: AiCuris Receives Orphan Drug Designation for Letermovir (AIC246) from FDA". Wuppertal. 2012-01-05
Apogenix GmbH. (1/5/12). "Press Release: Apogenix Raises € 7.5 Million to Further Advance APG101 to Treat Glioblastoma and other Tumors. All Existing Investors Participated in this Financing Round – Clinical Proof-of-concept Data with APG101 Expected in 2012-01-05
Epigenomics AG. (1/5/12). "Press Release: Epigenomics Biomarker Predicts Drug Resistance in Colorectal Cancer". Berlin & Seattle, WA. 2012-01-05
DASGIP AG. (1/5/12). "Press Release: Eppendorf Acquires DASGIP Group". Hamburg & Jülich. 2012-01-05
Forma Therapeutics. (1/5/12). "Press Release: Forma Therapeutics Announces Collaboration with Boehringer Ingelheim to Develop Novel Oncology Drugs". Watertown, MA. 2012-01-05
Bruker Corporation. (1/5/12). "Press Release: Bruker Energy & Supercon Technologies (BEST) Announces New Large Asian Order and Third Multi-year Superconductor Contract from MRI Manufacturer". Billerica, MA. 2012-01-05
Universität zu Lübeck. (1/5/12). "Pressemitteilung: Neuordnung der Universitätsmedizin in Schleswig-Holstein. Gemeinsame Presseeinladung der Christian-Albrechts-Universität zu Kiel und der Universität Lübeck". 2012-01-05
Basilea Pharmaceutica Ltd.. (1/5/12). "Press Release: Basilea to File Application for Marketing Authorization of Ceftobiprole for the Treatment of Pneumonia". Basel. 2012-01-05
AMP-Therapeutics GmbH. (1/5/12). "Press Release: AMP Therapeutics Completes A Round Financing". Leipzig. 2012-01-05
BRAIN AG. (1/4/12). "Press Release: Interim Status after Two Years of Co-operation. Joint RWE Power/Brain Project Reaches Strategically Important Milestone – Project Scope to Be Expanded Once More". Essen & Zwingenberg. 2012-01-04
Epigenomics AG. (1/4/12). "Press Release: Epigenomics Announces Initiation of PMA Filing for Epi proColon, Provides Update on Regulatory Timeline". Berlin & Seattle, WA. 2012-01-04
Probiodrug AG. (1/4/12). "Press Release: Probiodrug Raises Additional €15 Million to Advance Its Clinical Program". Halle (Saale). 2012-01-04
BASF SE. (1/3/12). "Press Release: BASF Participates in US American Technology Company Renmatix. BASF Led a $50 Million Financing Round – BASF Share of Investments Is $30 Million". Philadeliphia, PA & Ludwigshafen. 2012-01-03
Apogenix GmbH. (1/3/12). "Press Release: Apogenix Receives Additional EUR 2.3 Million BMBF Grant as Partner of the Biotech Cluster Rhine-Neckar". Heidelberg. 2012-01-03
Cellectis S.A.. (1/3/12). "Press Release: Cellectis Plant Sciences and Bayer CropScience Strenghten Genome Engineering Partnership". St. Paul, MN. 2012-01-03
Biognosys AG. (1/3/12). "Press Release: Biognosys and ETH Zurich Receive CHF 1.5m Funding from CTI". 2012-01-03
Evolva Holding S.A.. (1/2/12). "Press Release: Evolva in Collaboration with Roquette". Reinach. 2012-01-02
Ruhr-Universität-Bochum. (1/2/12). "Pressemitteilung: Proteine im Flug analysieren. Neues Massenspektrometer for RUB-Forscher – Technische Verstärkung für die Suche nach innovativen Antibiotika". Bochum. 2012-01-02
Galecto Biotech AB. (1/2/12). "Press Release: Galecto Biotech AB Receives Its Initial Financing in a Seed Round Co-led by Merck Serono Ventures and Novo A/S". Lund. 2012-01-02
GEOMAR – Helmholtz-Zentrum für Ozeanforschung Kiel. (1/1/12). "Pressemitteilung: Willkommen am GEOMAR! Helmholtz-Zentrum für Ozeanforschung Kiel gegründet". Kiel. 2012-01-01
Oncotyrol. (1/1/12). "Pressemitteilung: Den Krebs seiner Nische berauben. EU Projekt OPTATIO erforscht neue Strategien gegen das Multiple Myelom – Internationales Konsortium unter Innsbrucker Führung". Innsbruck. 2012-01-01
Sacura GmbH. (12/31/11). "Press Release: Founding of Sacura GmbH in January 2012". Münster. 2011-12-31
Intercell AG. (12/30/11). "Press Release: Thomas Szucs Elected New Chairman of Intercell’s Supervisory Board". Vienna. 2011-12-30
Bayer AG. (12/29/11). "Press Release: Submission in New Indication – Bayer’s Xarelto (Rivaroxaban) Submitted for U.S. Marketing Authorisation to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome". Berlin. 2011-12-29
CCS Cell Culture Service GmbH. (12/29/11). "Press Release: CCS Supplies Frozen Cells from EMD Millipore’s Cell Line Panel". Hamburg & Mammouth Junction, NJ. 2011-12-29
White & Chase. (12/27/11). "Pressemitteilung: White & Chase berät Banken bei Refinanzierung von Qiagen". München. 2011-12-27
Roche. (12/23/11). "Press Release: Roche Medicine Avastin Receives EU Approval for the Treatment of Women with Newly Diagnosed, Ovarian Cancer. Avastin Represents First Major Treatment Advance for Women with Ovarian Cencer in 15 Years". Basel. 2011-12-23
Bayer AG. (12/22/11). "Press Release: Bayer’s Xarelto (Rivaroxaban) Submitted for EU Marketing Authorisation for Secondary Prevention after an Acute Coronary Syndrome". Berlin. 2011-12-22
High-Tech Gründerfonds Management GmbH. (12/22/11). "Press Release: Eyesight & Vision GmbH. High-Tech Gründerfonds and Bayern Kapital Invest in Technology for Improved Cataract Eye Surgery". Nürnberg. 2011-12-22
MorphoSys AG. (12/21/11). "Press Release: MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients with Multiple Sclerosis". 2011-12-21
Bayer AG. (12/20/11). "Press Release: Bayer – Four Potential Blockbusters in the Pharma Pipeline. Good Prospects for Xarelto, VEGF Trap-Eye, Alpharadin and Regorafenib – Market Launches in the Next 18 Months Planned". Leverkusen. 2011-12-20
Bremen, Senator für Justiz und Verfassung. (12/20/11). "Pressemitteilung: Staatsrat Stauch stellt Bericht zu den Infektionen im Klinikum Bremen-Mitte vor [inkl. vollständigem Bericht als Anhang]". 2011-12-20
European ScreeningPort GmbH. (12/20/11). "Press Release: Translational Lab for Biomarker Discovery. European ScreeningPort (ESP) Has Set Up a Facility for Biomarker Discovery at the University Medical Center Hamburg-Eppendorf". Hamburg. 2011-12-20
bio.logis GmbH. (12/20/11). "Pressemitteilung: bio.logis schließt Serie-B-Finanzierungsrunde über 4,3 Mio. € ab". Frankfurt am Main. 2011-12-20
Novartis AG. (12/20/11). "Press Release: Novartis Announces Termination of ALTITUDE Study with Rasilez/Tekturna in High-risk Patients with Diabetes and Renal Impairment". Basel. 2011-12-20
Sanofi S.A.. (12/20/11). "Press Release: Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis". Paris. 2011-12-20
Scil Technology GmbH. (12/20/11). "Press Release: Sanofi Licenses Worldwide Rights on Regenerative Treatment for Osteoarthritis and Cartilage Disorders from Scil Technology GmbH". Martinsried. 2011-12-20
MacroGenics, Inc.. (12/20/11). "Press Release: MacroGenics Receives Milestone Payment as Part of Its Global DART Alliance with Boehringer Ingelheim". Rockville, MD. 2011-12-20
Bayer AG. (12/19/11). "Press Release: Bayer’s Xarelto Approved in the EU for the Prevention of Stroke in Patients with AF and in the Treatment of DVT". Berlin. 2011-12-19
Norgenta Norddeutsche Life Science Agentur. (12/19/11). "Pressemitteilung: Neue Spitze beim Clustermanagement von Life Science Nord". Kiel & Hamburg. 2011-12-19
Paion AG. (12/19/11). "Press Release: Paion Announces Restructuring. Significant Cost Reduction Due to Restructuring of the Company". Aachen. 2011-12-19
Pressure BioSciences, Inc.. (12/19/11). "Press Release: Pressure BioSciences, Inc. Announces Distribution Agreement with IUL Instruments GmbH for Germany and Switzerland". South Easton, MA. 2011-12-19
Bayer AG. (12/16/11). "Press Release: Bayer CropScience and Performance Plants Sign License Agreement on Cotton Yield Improvement". Monheim. 2011-12-16
Biofrontera AG. (12/16/11). "Press Release: European Commission Authorizes EU-wide Marketing and Distribution of Biofrontera’s Ameluz (Ad hoc in accordance with sec. 15 WpHG)". Leverkusen. 2011-12-16
Roche. (12/16/11). "Press Release: Roche’s Personalized Medicine Zelboraf Receives Positive Opinion from European Authority for the Treatment of People with BRAF Mutation-positive Metastatic Melanoma". Basel. 2011-12-16
Axela. (12/15/11). "Press Release: Sony DADC and Axela to Develop Smart Consumables for Real Time Multiplex Immunoassays". Salzburg & Toronto. 2011-12-15
Bayer AG. (12/15/11). "Press Release: Settlement Agreements with U.S. Long-grain Rice Growers Have Taken Efffect". Monheim. 2011-12-15
Aldevron LLC. (12/15/11). "Press Release: Aldevron to Generate Antibodies for Erythropoietin Research Consortium. Aldevron Announces Participation in a Three Year, €3.9 Million Research Project to Study the Long-term Risks of Erythropoietin Use". 2011-12-15
MorphoSys AG. (12/15/11). "Press Release: MorphoSys and Novozymes Sign Long-term Alliance on Slonomics Technology for Industrial Biotechnology Applications". 2011-12-15
Novartis AG. (12/15/11). "Press Release: Novartis Drug Gilenya Showed Positive Clinical Outcomes for Relapsing-remitting MS Patients in Third Large Phase III Clinical Trial". Basel. 2011-12-15
Sygnis Pharma AG. (12/15/11). "Press Release: Sygnis Announces Key Results of Its Phase II Trial of AX200 in Acute Ischemic Stroke. The Study Missed Its Endpoints". Heidelberg. 2011-12-15
Roche. (12/15/11). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2011-12-15
Galenica Holding AG. (12/15/11). "Press Release: FDA Assigns PDUFA Date for Injectafer NDA". Bern. 2011-12-15
Analytik Jena AG. (12/15/11). "Press Release: Analytik Jena AG Announces Group Figures for Financial Year 2010/11". Jena. 2011-12-15
SAW Instruments GmbH. (12/15/11). "Press Release: Successful North American Product Launch Prompts Saw Instruments to Extend samX Early Adopter Price Promotion". Bonn. 2011-12-15
High-Tech Gründerfonds Management GmbH. (12/14/11). "Press Release: BVMed, Earlybird and High-Tech Gründerfonds Launch »MedTech Radar« – a Media Service about Innovations in Medical Technology". Berlin, Bonn & Hamburg. 2011-12-14
4SC AG. (12/14/11). "Press Release: 4SC Forms Subsidiary to Commercialise Innovative Early-stage Drug Research Programmes and Strengthen Revenue from Research Collaborations". Planegg-Martinsried. 2011-12-14
Biohit Oyj. (12/14/11). "Press Release: Biohit Oyj and Sartorius Lab Holding GmbH Complete Sale of Liquid Handling Business, Biohit Oyj Revises Risk Outlook". 2011-12-14
Biohit Oyj. (12/14/11). "Press Release: Semi Korpela Appointed New President and CEO of Biohit Oyj". 2011-12-14
Boehringer Ingelheim. (12/14/11). "Press Release: Boehringer Ingelheim Significantly Expands Its Supply Center for China". Shanghai & Ingelheim. 2011-12-14
Protaffin Biotechnologie AG. (12/14/11). "Press Release: Protaffin AG Receives Key Grant for Preclinical and Clinical Development of PA401 in Inflammatory Lung Disease". Graz & London. 2011-12-14
SAW Instruments GmbH. (12/14/11). "Press Release: SAW Instruments and Acobio K.K. Sign Exclusive Agreement to Distribute sam Biosensors in Japan. Japanese Company to Launch the New samX at the Annual Meeting of Molecular Biology Society of Japan". Yokoha 2011-12-14
Bayer AG. (12/14/11). "Press Release: New Intrauterine System for Long-term Contraception Submitted for Marketing Authorization both in the EU and the US. Once Approved, the New Low Dose IUS Will Offer Young Women Contraception for Up to Three Years". Be 2011-12-14
Evolva Holding S.A.. (12/14/11). "Press Release: Evolva Obtains Patent Coverage in Russia on EV-077 for Use in Complications of Diabetes". Reinach. 2011-12-14
Analytik Jena AG. (12/13/11). "Press Release: Partnership in Japan. Analytik Jena Adds X-ray Fluorescence Spectroscopy to Its Product Portalio and Begins Sales in Japan". Jena & Yokohama. 2011-12-13
Pieris AG. (12/13/11). "Press Release: Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin Program at ASH Annual Meeting. Breadth of Pharmacokinetic Data Points to Tunable Half-life for Platform". San Diego, CA. 2011-12-13
Curetis AG. (12/13/11). "Press Release: Collaboration Agreement with Sanofi Pasteur". 2011-12-13
Curetis AG. (12/13/11). "Press Release: Curetis AG Appoints Dr. Klaus Brinkmann as Director of Sales. Preparation of CE-marking and Product Launch in Europe in 2012". Holzgerlingen. 2011-12-13
High-Tech Gründerfonds Management GmbH. (12/13/11). "Press Release: HTGF, Bayern Kapital and Dr. Dieter Manstein Invest in GME Medical Engineering GmbH". Bonn, Landshut & Nürnberg. 2011-12-13
Ventana Medical Systems, Inc.. (12/12/11). "Press Release: Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-promotion Agreement for Fully Automated RNA In Situ Hybridzation Assay Systems". Tuscon, AZ. 2011-12-12
Biotest AG. (12/12/11). "Press Release: Clinical Development of BT-062 in Multiple Myeloma Expands into Combination Therapy". Dreieich. 2011-12-12
EKAH (Eidgenössische Ethikkommission für die Biotechnologie im Ausserhumanbereich). (12/12/11). "Pressemitteilung: Ende November 2013 läuft das Moratorium für den kommerziellen Anbau gentechnisch veränderter Planzen aus. Nach Auffassung der Mehrheit der 2011-12-12
Cytoo S.A.. (12/12/11). "Press Release: Cytoo, Cenix BioScience and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 M€ EU FP7 Grant to Launch MEHTRICS Consortium". 2011-12-12
Medigene AG. (12/12/11). "Press Release: Veregen Marketing Approval Process Initiated for 17 Additional European Countries. Decision on Marketing Approvals Expected End of Q1 2012". Martinsried. 2011-12-12
Metabolomic Discoveries GmbH. (12/12/11). "Press Release: New Service Platform for Sustainable and Competitive Biotechnological Processes. Insilico Biotechnology and Metabolomic Discoveries Have Agreed to Pool Their Expertise". 2011-12-12
next pagenext page 1 2 3 ... 75 76 77 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top